For instance, following the recent finding that plasma IP-10 may serve as an early biomarker for anti-TB chemotherapy response21, let us assume for the sake of argument that one patient experiences a decrease of 20% in IP-10 during treatment. The gene discussed is CXCL10; the disease is tuberculosis.